Small nucleolar RNAs in cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1826, Issue 1, 2012, Pages 121-128

  Mannoor, Kaiissar ^a   Liao, Jipei ^a   Jiang, Feng ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Diagnosis; Non coding RNAs; Small nucleolar RNAs; Therapy

Indexed keywords

CASPASE 3; MICRORNA; PROTEIN P53; SMALL INTERFERING RNA; SMALL NUCLEOLAR RNA; TELOMERASE; UNTRANSLATED RNA;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL TRANSFORMATION; DIAGNOSTIC VALUE; GENE DELETION; GENE SILENCING; HEAD AND NECK CANCER; HUMAN; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MENINGIOMA; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE; RNA METABOLISM; RNA METHYLATION; RNA PSEUDOURIDYLATION;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; RNA, SMALL NUCLEOLAR; RNA, UNTRANSLATED; TUMOR MARKERS, BIOLOGICAL;

EID: 84860217230     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2012.03.005     Document Type: Review

References (110)

1. American Cancer Society Cancer Facts & Figures 2011.
2. Croce C.M. Oncogenes and cancer. N. Engl. J. Med. 2008, 358(5):502-511.
3. Stein L.D. Human genome: end of the beginning. Nature 2004, 431:915-916.
4. Pennisi E. A low number wins the GeneSweep pool. Science 2003, 300:1484.
5. Cheng J., Kapranov P., Drenkow J., Dike S., Brubaker S., Patel S., Long J., Stern D., Tammana H., Helt G., Sementchenko V., Piccolboni A., Bekiranov S., Bailey D.K., Ganesh M., Ghosh S., Bell I., Gerhard D.S., Gingeras T.R. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 2005, 308:1149-1154.
6. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigó R., Gingeras T.R., Margulies E.H., Weng Z., Snyder M., Dermitzakis E.T., Thurman R.E., Kuehn M.S., Taylor C.M., Neph S., Koch C.M., Asthana S., Malhotra A., Adzhubei I., Greenbaum J.A., Andrews R.M., Flicek P., Boyle P.J., Cao H., Carter N.P., Clelland G.K., Davis S., Day N., Dhami P., Dillon S.C., Dorschner M.O., Fiegler H. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816.
7. Mattick J.S., Makunin I.V. Non-coding RNA. Hum. Mol. Genet. 2006, 15(1):R17-R29.
8. Taft R.J., Pang K.C., Mercer T.R., Dinger M., Mattick J.S. Non-coding RNAs: regulators of disease. J. Pathol. 2010, 220(2):126-139.
9. Will C.L., Luhrmann R. The RNA World 2006, 369-400. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. 3rd edition. R.F. Gesteland, R. Cech, A.J. Atkins (Eds.).
10. Nana-Sinkam P., Croce C.M. MicroRNAs in diagnosis and prognosis in cancer: what does the future hold?. Pharmacogenomics 2010, 11(5):667-669.
11. Qu H., Xu W., Huang Y., Yang S. Circulating miRNAs: promising biomarkers of human cancer. Asian Pac. J. Cancer Prev. 2011, 12(5):1117-1125.
12. Duttagupta R., Jiang R., Gollub J., Getts R.C., Jones K.W. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 2011, 6(6):e20769.
13. Shen J., Todd N.W., Zhang H., Yu L., Lingxiao X., Mei Y., Guarnera M., Liao J., Chou A., Lu C.L., Jiang Z., Fang H., Katz R.L., Jiang F. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab. Invest. 2011, 91(4):579-587.
14. Xie Y., Todd N.W., Liu Z., Zhan M., Fang H., Peng H., Alattar M., Deepak J., Stass S.A., Jiang F. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 2010, 67(2):170-176.
15. Saito A.J., Schetter M., Mollerup S., Kohno T., Skaug V., Bowman E.D., Mathé E.A., Takenoshita S., Yokota J., Haugen A., Harris C.C. The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma, A retrospective analysis of three cohorts. Clin. Cancer Res. 2011, 17(7):1875-1882.
16. Cortez M.A., Bueso-Ramos C., Ferdin J., Lopez-Berestein G., Sood A.K., Calin G.A. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 2011, 8(8):467-477.
17. Garzon R., Marcucci G., Croce C.M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov. 2010, 9:775-789.
18. Valencia-Sanchez M.A., Liu J., Hannon G.J., Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006, 20:515-524.
19. Pillai R.S., Bhattacharyya S.N., Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms?. Trends Cell Biol. 2007, 17:118-126.
20. Zhang B., Pan X., Cobb G.P., Anderson T.A. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007, 302(1):1-12.
21. Galasso M., Elena S.M., Volinia S. Non-coding RNAs: a key to future personalized molecular therapy?. Genome Med. 2010, 2(2):12-21.
22. Williams G.T., Farzaneh F. Are snoRNAs and snoRNA host genes new players in cancer?. Nat. Rev. Cancer 2012, 12:84-88.
23. Viltteri W. Mining the transcrptome-methods and applications 2006, Royal Institute of Technology, School of Biotechnology, Stockholm.
24. Gardner P.P., Bateman A., Poole A.M. SnoPatrol: how many snoRNA genes are there?. J. Biol. 2010, 9:4-7.
25. Lafontaine D.L., Tollervey D. Birth of the snoRNPs: the evolution of the modification-guide snoRNAs. Trends Biochem. Sci. 1998, 23(10):383-388.
26. Terns M.P., Terns R.M. Small nucleolar RNAs: versatile trans-acting molecules of ancient evolutionary origin. Gene Expr. 2002, 10(1-2):17-39.
27. Weinstein L.B., Steitz J.A. Guided tours: from precursor snoRNA to functional snoRNP. Curr. Opin. Cell Biol. 1999, 11(3):378-384.
28. Smith C.M., Steitz J.A. Sno storm in the nucleolus: new roles for myriad small RNPs. Cell 1997, 89:669-672.
29. Bortolin M.L., Kiss T. Human U19 intron-encoded snoRNA is processed from a long primary transcript that possesses little potential for protein coding. RNA 1998, 4:445-454.
30. Smith C.M., Steitz J.A. Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol. Cell. Biol. 1998, 18(12):6897-6909.
31. Cavaillé J., Bachellerie J.P. SnoRNA-guided ribose methylation of rRNA: structural features of the guide RNA duplex influencing the extent of the reaction. Nucleic Acids Res. 1998, 26(7):1576-1587.
32. Kiss T. Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs. EMBO J. 2001, 20(14):3617-3622.
33. Bachellerie J.P., Cavaillé J., Hüttenhofer A. The expanding snoRNA world. Biochimie 2002, 84(8):775-790.
34. Kiss A.M., Jády B.E., Bertrand E., Kiss T. Human Box H/ACA Pseudouridylation Guide RNA Machinery. Mol. Cell. Biol. 2004, 24(13):5797-5807.
35. Ganot P., Caizergues-Ferrer M., Kiss T. The family of box ACA small nucleolar RNAs is defined by an evolutionarily conserved secondary structure and ubiquitous sequence elements essential for RNA accumulation. Genes Dev. 1997, 11(7):941-956.
36. Decatur W.A., Fournier M.J. rRNA modifications and ribosome function. Trends Biochem. Sci. 2002, 27(7):344-351.
37. Nizami Z., Deryusheva S., Gall J.G. The Cajal Body and Histone Locus Body. Cold Spring Harb. Perspect. Biol. 2010, 2:a000653.
38. Kishore S., Stamm S. The snoRNA HBII-52 Regulates Alternative Splicing of the Serotonin Receptor 2C. Science 2006, 311(5758):230-232.
39. Cavaillé J., Buiting K., Kiefmann M., Lalande M., Brannan C.I., Horsthemke B., Bachellerie J.P., Brosius J., Hüttenhofer A. Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(26):14311-14316.
40. Ender C., Krek A., Friedländer M.R., Beitzinger M., Weinmann L., Chen W., Pfeffer S., Rajewsky N., Meister G. A human snoRNA with microRNA-like functions. Mol. Cell 2008, 32(4):519-528.
41. Kishore S., Khanna A., Zhang Z., Hui J., Balwierz P.J., Stefan M., Beach C., Nicholls R.D., Zavolan M., Stamm S. The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. Hum. Mol. Genet. 2010, 19(7):1153-1164.
42. Ono M., Scott M.S., Yamada K., Avolio F., Barton G.J., Lamond A.I. Identification of human miRNA precursors that resemble box C/D snoRNAs. Nucleic Acids Res. 2011, 39(9):3879-3891.
43. Brameier M., Herwig A., Reinhardt R., Walter L., Gruber J. Human box C/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs. Nucleic Acids Res. 2011, 39(2):675-686.
44. Scott M.S., Ono M. From snoRNA to miRNA: Dual function regulatory non-coding RNAs. Biochimie 2011, 93:1987-1992.
45. Mitchell J.R., Cheng J., Collins K. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end. Mol. Cell. Biol. 1999, 19:567-576.
46. Pogacic V., Dragon F., Filipowicz W. Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol. Cell. Biol. 2000, 20:9028-9040.
47. Dez C., Henras A., Faucon B., Lafontaine D., Caizergues-Ferrer M., Henry Y. Stable expression in yeast of the mature form of human telomerase RNA depends on its association with the box H/ACA small nucleolar RNP proteins Cbf5p, Nhp2p and Nop10p. Nucleic Acids Res. 2001, 29:598-603.
48. Skryabin B.V., Gubar L.V., Seeger B., Pfeiffer J., Handel S., Robeck T., Karpova E., Rozhdestvensky T.S., Brosius J. Deletion of the MBII-85 snoRNA gene cluster in mice results in postnatal growth retardation. PLoS Genet. 2007, 3(12):e235.
49. Sahoo T., del Gaudio D., German J.R., Shinawi M., Peters S.U., Person R.E., Garnica A., Cheung S.W., Beaudet A.L. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat. Genet. 2008, 40(6):719-721.
50. Ding F., Li H.H., Zhang S., Solomon N.M., Camper S.A., Cohen P., Francke U. SnoRNA Snord116 (Pwcr1/MBII-85) deletion causes growth deficiency and hyperphagia in mice. PLoS One 2008, 3(3):e1709.
51. Chang L.S., Lin S.Y., Lieu A.S., Wu T.L. Differential expression of human 5S snoRNA genes. Biochem. Biophys. Res. Commun. 2002, 299:196-200.
52. Donsante A., Miller D.G., Li Y., Vogler C., Brunt E.M., Russell D.W., Sands M.S. AAV vector integration sites in mouse hepatocellular carcinoma. Science 2007, 317:477.
53. Dong X.Y., Rodriguez C., Guo P., Sun X., Talbot J.T., Zhou W., Petros J., Li Q., Vessella R.L., Kibel A.S., Stevens V.L., Calle E.E., Dong J.T. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum. Mol. Genet. 2008, 17(7):1031-1042.
54. Dong X.Y., Guo P., Boyd J., Sun X., Li Q., Zhou W., Dong J.T. Implication of snoRNA U50 in human breast cancer. J. Genet. Genomics 2009, 8:447-454.
55. Tanaka R., Satoh H., Moriyama M., Satoh K., Morishita Y., Yoshida S., Watanabe T., Nakamura Y., Mori S. Intronic U50 small-nucleolar-RNA (snoRNA) host gene of no protein-coding potential is mapped at the chromosome breakpoint t(3;6)(q27;q15) of human B-cell lymphoma. Genes Cells 2000, 5(4):277-287.
56. Mourtada-Maarabouni M., Pickard M.R., Hedge V.L., Farzaneh F., Williams G.T. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009, 28:195-208.
57. Nakamura Y., Takahashi N., Kakegawa E., Yoshida K., Ito Y., Kayano H., Niitsu N., Jinnai I., Bessho M. The GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a result of t(1;3)(q25;q27) in a patient with B-cell lymphoma. Cancer Genet. Cytogenet. 2008, 182(2):144-149.
58. Liao J., Yu L., Mei Y., Guarnera M., Shen J., Li R., Liu Z., Jiang F. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol. Cancer 2010, 27(9):198-207.
59. Li R., Wang H., Bekele B.N., Yin Z., Caraway N.P., Katz R.L., Stass S.A., Jiang F. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene 2006, 18:2628-2635.
60. Jiang F., Yin Z., Caraway N.P., Li R., Katz R.L. Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays. Neoplasia 2004, 6:623-635.
61. Gebhart E. Double minutes, cytogenetic equivalents of gene amplification, in human neoplasia - a review. Clin. Transl. Oncol. 2005, 7:477-485.
62. Schwab M. Oncogene amplification in solid tumors. Semin. Cancer Biol. 1999, 9:319-325.
63. Bell D.W. Our changing view of the genomic landscape of cancer. J. Pathol. 2010, 220:231-243.
64. Gee H.E., Buffa F.M., Camps C., Ramachandran A., Leek R., Taylor M., Patil M., Sheldon H., Betts G., Homer J., West C., Ragoussis J., Harris A.L. The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br. J. Cancer 2011, 104:1168-1177.
65. Jelinic P., Shaw P. Loss of imprinting and cancer. J. Pathol. 2007, 211(3):261-268.
66. Jirtle R.L. Genomic Imprinting and Cancer. Exp. Cell Res. 1994, 248:18-24.
67. Benetatos L., Vartholomatos G., Hatzimichael E. MEG3 imprinted gene contribution in tumorigenesis. Int. J. Cancer 2011, 129:773-779.
68. Seitz H., Royo H., Bortolin M.L., Lin S.P., Ferguson-Smith A.C., Cavaille J. A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res. 2004, 14:1741-1748.
69. Lin S.P., Youngson N., Takada S., Seitz H., Reik W., Paulsen M., Cavaille J., Ferguson-Smith A.C. Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12. Nat. Genet. 2003, 35:97-102.
70. Shimoda M., Morita S., Obata Y., Sotomaru Y., Kono T., Hatada I. Imprinting of a small nucleolar RNA gene on mouse chromosome 12. Genomics 2002, 79:483-486.
71. da Rocha S.T., Edwards C.A., Ito M., Ogata T., Ferguson-Smith A.C. Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends Genet. 2008, 24:306-316.
72. Kagami M., Sekita Y., Nishimura G., Irie M., Kato F., Okada M., Yamamori S., Kishimoto H., Nakayama M., Tanaka Y., Matsuoka K., Takahashi T., Noguchi M., Tanaka Y., Masumoto K., Utsunomiya T., Kouzan H., Komatsu Y., Ohashi H., Kurosawa K., Kosaki K., Ferguson-Smith A.C., Ishino F., Ogata T. Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nat. Genet. 2008, 40:237-242.
73. Cavaillé J., Seitz H., Paulsen M., Ferguson-Smith A.C., Bachellerie J.P. Identification of tandemly-repeated C/D snoRNA genes at the imprinted human 14q32 domain reminiscent of those at the Prader-Willi/Angelman syndrome region. Hum. Mol. Genet. 2002, 11(13):1527-1538.
74. Ko J.M., Yau W.L., Chan P.L., Lung H.L., Yang L., Lo P.H., Tang J.C., Srivastava G., Stanbridge E.J., Lung M.L. Functional evidence of decreased tumorigenicity associated with monochromosome transfer of chromosome 14 in esophageal cancer and the mapping of tumor-suppressive regions to 14q32. Genes Chromosomes Cancer 2005, 43(3):284-293.
75. Blackburn E.H. Telomerases. Annu. Rev. Biochem. 1992, 61:113-129.
76. de Lange T. Stringent sequence requirements for the formation of human telomeres. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2882-2885.
77. Feng J., Funk W.D., Wang S., Weinrich S.L., Avilion A.A., Chiu C., Adams R.R., Chang E., Allsopp R.C., Yu J., Le S., West M.D., Harley C.B., Andrews W.H., Greider C.W., Villeponteau B. The RNA component of human telomerase. Science 1995, 269:1236-1241.
78. Lingner J., Hughes T.R., Shevchenko A., Mann M., Lundblad V., Cech T.R. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 1997, 276:561-567.
79. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D., Ziaugra L., Beijersbergern R.L., Davidoff M.J., Liu Q., Bacchetti S., Haber D.A., Weinberg R.A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997, 90:785-795.
80. Harley C.B. Telomere loss: mitotic clock or genetic time bomb?. Mutat. Res. 1991, 256:271-282.
81. Sharma H.W., Maltese J.Y., Zhu X., Kaiser H.E., Narayanan R. Telomeres, telomerase and cancer: is the magic bullet real?. Anticancer Res. 1996, 16:511-515.
82. Nakano K., Watney E., McDougall J.K. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am. J. Pathol. 1998, 153(3):857-864.
83. Yan P., Coindre J.M., Benhattar J., Bosman F.T., Guillou L. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity. Cancer Res. 1999, 59:3166-3170.
84. Trahan C., Dragon F. Dyskeratosis congenita mutations in the H/ACA domain of human telomerase RNA affect its assembly into a pre-RNP. RNA 2009, 15(2):235-243.
85. Alter B.P., Giri N., Savage S.A., Rosenberg P.S. Cancer in dyskeratosis congenital. Blood 2009, 113(26):6549-6557.
86. Sieron P., Hader C., Hatina J., Engers R., Wlazlinski A., Müller M., Schulz W.A. DKC1 overexpression associated with prostate cancer progression. Br. J. Cancer 2009, 101:1410-1416.
87. Montanaro L., Bigotti M., Clohessy J., Barbieri S., Ceccarelli C., Santini D., Taufurelli M., Calienti M., Teruya-Feldstein J., Trere D., Pandolfi P.P., Derenzini M. Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J. Pathol. 2006, 210:10-18.
88. Zhang Y., Morimoto K., Danilova N., Zhang B., Lin S. Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing. PLoS One 2012, 7:e30188.
89. Pereboom T.C., van Weele L.J., Bondt A., MacInnes A.W. A zebrafish model of dyskeratosis congenita reveals hematopoietic stem cell formation failure resulting from ribosomal protein-mediated p53 stabilization. Blood 2011, 118(20):5458-5465.
90. Watkins N.J., Bohnsack M.T. The box C/D and H/ACA snoRNPs: key players in the modification, processing and the dynamic folding of ribosomal RNA. Mol. Biosyst. 2010, 6(3):481-493.
91. King T.H., Liu B., McCully R.R., Fournier M.J. Ribosome structure and activity are altered in cells lacking snoRNPs that form pseudouridines in the peptidyl transferase center. Mol. Cell 2003, 11:425-435.
92. Cui Z., DiMario P.J. RNAi knockdown of Nopp 140 induces Minute-like phenotypes in Drosophila. Mol. Biol. Cell 2007, 18:2179-2191.
93. Isaac C., Marsh K.L., Paznekas W.A., Dixon J., Dixon M.J., Jabs E.W., Meier U.T. Characterization of the nucleolar gene product, treacle, in Treacher Collins syndrome. Mol. Biol. Cell 2000, 11(9):3061-3071.
94. Krastev D.B., Slabicki M., Paszkowski-Rogacz M., Hubner N.C., Junqueira M., Shevchenko A., Mann M., Neugebauer K.M., Buchholz F. A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly. Nat. Cell Biol. 2011, 10.1038/ncb2264.
95. Ruggero D., Pandolf P.P. Does the ribosome translate cancer?. Nat. Rev. Cancer 2003, 3:179-192.
96. Ruggero D., Grisendi S., Piazza F., Rego E., Mari F., Rao P.H., Cordon-Cardo C., Pandolfi P.P. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 2003, 299:259-262.
97. Montanaro L. Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer. J. Pathol. 2010, 222:345-349.
98. Killian A., Le Meur N., Sesboue R., Bourguignon J., Bougeard G., Gautherot J., Bastard C., Frébourg T., Flaman J.M. Inactivation of the RRB1-Pescadillo pathway involved in ribosome biogenesis induces chromosomal instability. Oncogene 2004, 23:8597-8602.
99. Berthon J., Fujikane R., Forterre P. When DNA replication and protein synthesis come together. Trends Biochem. Sci. 2009, 34(9):429-434.
100. Nallar S.C., Lin L., Srivastava V., Gade P., Hofmann E.R., Ahmed H., Reddy S.P., Kalvakolanu D.V. GRIM-1, a Novel Growth Suppressor, Inhibits rRNA Maturation by Suppressing Small Nucleolar RNAs. PLoS One 2011, 6(9):e24082.
101. Nakamoto K., Ito A., Watabe K., Koma Y., Asada H., Yoshikawa K., Shinomura Y., Matsuzawa Y., Nojima H., Kitamura Y. Increased expression of a nucleolar Nop5/Sik family member in metastatic melanoma cells: evidence for its role in nucleolar sizing and function. Am. J. Pathol. 2001, 159(4):1363-1374.
102. Amsterdam A., Sadler K.C., Lai K., Farrington S., Bronson R.T., Lees J.A., Hopkins N. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2004, 2(5):E139.
103. Michel C.I., Holley C.L., Scruggs B.S., Sidhu R., Brookheart R.T., Listenberger L.L., Behlke M.A., Ory D.S., Schaffer J.E. Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab. 2011, 14(1):33-44.
104. Mei Y.P., Liao J.P., Shen J.P., Yu L., Liu B.L., Liu L., Li R.Y., Ji L., Dorsey S.G., Jiang Z.R., Katz R.L., Wang J.Y., Jiang F. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene 2011, 449:1-11.
105. Albertson D.G., Ylstra B., Segraves R., Collins C., Dairkee S.H., Kowbel D., Kuo W.L., Gray J.W., Pinkel D. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 2000, 25(2):144-146.
106. Taguchi T., Cheng G.Z., Bell D.W., Balsara B., Liu Z., Siegfried J.M., Testa J.R. Combined chromosome microdissection and comparative genomic hybridization detect multiple sites of amplification DNA in a human lung carcinoma cell line. Genes Chromosomes Cancer 1997, 20(2):208-212.
107. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
108. Vousden K.H. Activation of the p53 tumor suppressor protein. Biochim. Biophys. Acta 2002, 1602:47-59.
109. Xiao J., Lin H., Luo X., Luo X., Wang Z. miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress. EMBO J. 2011, 30(3):524-532.
110. Appaiah H.N., Goswami C.P., Mina L.A., Badve S., Sledge G.W., Liu Y., Nakshatri H. Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients. Breast Cancer Res. 2011, 13(5):R86.